Skip to content
Skip to content

AI-Powered Oral Board Training Is Available to CTSNet Users Now!

LEARN MORE
Not a member yet? Register now.
  • ABOUT
    • Leadership
    • Participation
    • Featured Sponsors
    • Submission Guidelines
    • Competitions
      • Innovation Video Competition
    • Community
      • Volunteer
      • Badges
    • Contact Us
  • EXPLORE CTSNET
    • CARDIAC
    • THORACIC
    • CONGENITAL
    • Clinical Care Professionals
    • JANS
    • Events
    • Journals
  • Videos
    • Atlas of Cardiac Surgery
    • Webinars
    • Master Class
    • Guest Interviews
    • Conference Sessions
  • Podcasts
    • The Beat With Joel Dunning
    • The Atrium
    • The Cardiac Recovery Room
    • The Lifeline
  • Profiles
    • Users Directory
    • Organizations
  • CAREERS
    • US Career Center
    • European Career Center
  • ABOUT
    • Leadership
    • Participation
    • Featured Sponsors
    • Submission Guidelines
    • Competitions
      • Innovation Video Competition
    • Community
      • Volunteer
      • Badges
    • Contact Us
  • EXPLORE CTSNET
    • CARDIAC
    • THORACIC
    • CONGENITAL
    • Clinical Care Professionals
    • JANS
    • Events
    • Journals
  • Videos
    • Atlas of Cardiac Surgery
    • Webinars
    • Master Class
    • Guest Interviews
    • Conference Sessions
  • Podcasts
    • The Beat With Joel Dunning
    • The Atrium
    • The Cardiac Recovery Room
    • The Lifeline
  • Profiles
    • Users Directory
    • Organizations
  • CAREERS
    • US Career Center
    • European Career Center
SUBMIT CONTENT
DONATE
JOIN

AI-Powered Oral Board Training Is Available to CTSNet Users Now!

READ MORE
  • ABOUT
    • Leadership
    • Participation
    • Featured Sponsors
    • Submission Guidelines
    • Competitions
      • Innovation Video Competition
    • Community
      • Volunteer
      • Badges
    • Contact Us
  • EXPLORE CTSNET
    • CARDIAC
    • THORACIC
    • CONGENITAL
    • Clinical Care Professionals
    • JANS
    • Events
    • Journals
  • Videos
    • Atlas of Cardiac Surgery
    • Webinars
    • Master Class
    • Guest Interviews
    • Conference Sessions
  • Podcasts
    • The Beat With Joel Dunning
    • The Atrium
    • The Cardiac Recovery Room
    • The Lifeline
  • Profiles
    • Users Directory
    • Organizations
  • CAREERS
    • US Career Center
    • European Career Center
Not a member yet? Register now.
  • ABOUT
    • Leadership
    • Participation
    • Featured Sponsors
    • Submission Guidelines
    • Competitions
      • Innovation Video Competition
    • Community
      • Volunteer
      • Badges
    • Contact Us
  • EXPLORE CTSNET
    • CARDIAC
    • THORACIC
    • CONGENITAL
    • Clinical Care Professionals
    • JANS
    • Events
    • Journals
  • Videos
    • Atlas of Cardiac Surgery
    • Webinars
    • Master Class
    • Guest Interviews
    • Conference Sessions
  • Podcasts
    • The Beat With Joel Dunning
    • The Atrium
    • The Cardiac Recovery Room
    • The Lifeline
  • Profiles
    • Users Directory
    • Organizations
  • CAREERS
    • US Career Center
    • European Career Center
  • ABOUT
    • Leadership
    • Participation
    • Featured Sponsors
    • Submission Guidelines
    • Competitions
      • Innovation Video Competition
    • Community
      • Volunteer
      • Badges
    • Contact Us
  • EXPLORE CTSNET
    • CARDIAC
    • THORACIC
    • CONGENITAL
    • Clinical Care Professionals
    • JANS
    • Events
    • Journals
  • Videos
    • Atlas of Cardiac Surgery
    • Webinars
    • Master Class
    • Guest Interviews
    • Conference Sessions
  • Podcasts
    • The Beat With Joel Dunning
    • The Atrium
    • The Cardiac Recovery Room
    • The Lifeline
  • Profiles
    • Users Directory
    • Organizations
  • CAREERS
    • US Career Center
    • European Career Center
SUBMIT CONTENT
DONATE
JOIN
You are here:
  1. Cardiac

TAVR for intermediate-risk patients: the PARTNER 2 trial

  • April 3, 2016

Submitted by: Stuart Head

Source: N Engl J Med
Source URL: http://www.nejm.org/doi/full/10.1056/NEJMoa1514616

Keywords:

Author(s): Martin B. Leon, Craig R. Smith, Michael J. Mack, Raj R. Makkar, Lars G. Svensson, Susheel K. Kodali, Vinod H. Thourani, E. Murat Tuzcu, D. Craig Miller, Howard C. Herrmann, Darshan Doshi, David J. Cohen, Augusto D. Pichard, Samir Kapadia, Todd Dewey, Vasilis Babaliaros, Wilson Y. Szeto, Mathew R. Williams, Dean Kereiakes, Alan Zajarias, Kevin L. Greason, Brian K. Whisenant, Robert W. Hodson, Jeffrey W. Moses, Alfredo Trento, David L. Brown, William F. Fearon, Philippe Pibarot, Rebecca T. Hahn, Wael A. Jaber, William N. Anderson, Maria C. Alu, and John G. Webb, for the PARTNER 2 Investigators

The PARTNER 2A trial randomized 2032 patients at intermediate operative risk (mean STS score of 6) to undergo either transcatheter or surgical aortic valve replacement. The primary endpoint of all-cause death or disabling stroke at 2 years was comparable for the two treatments: TAVR 19.3% versus SAVR 21.1%. A subgroup analysis of patients eligible for transfemoral aortic valve replacement even suggested superior outcomes for TAVR as compared to surgery (HR 0.79, 95% CI 0.62-1.00, P=0.05).

2 Comments

  1. Constantinos Lovoulos says:
    April 22, 2016 at 6:16 pm

    In case of TAVR bio prosthetic failure over time, size limitations, or another type of cardiac pathology (CAD or MV disease), the need for another cardiothoracic surgical intervention arises via mediasternotomy or minimally invasive approach, do the authors have any comments on the degree of difficulty of entering the pericardial cavity? Considering the deployment forces of the TAVR valve I would expect a cemented aorta to the PA, RA, and RV.
    By constantly broadening the candidate population for TAVR, are we indicating to our patients that in 5, 10 or 15 years we will not be implanting mechanical aortic valves?

     Log in to Reply
  2. Ghassan Musleh says:
    April 23, 2016 at 2:34 am

    One of the main limitations of TAVR is the lack of knowledge about its intermediate and long term durability.
    Doing more TAVR in low risk cases means the high chance they will come for redo valve wheather it is TAVR OR SAVR.
    in case the patient needed surgery then It will be an operation from hell.

     Log in to Reply

Add Comments Cancel reply

You must be logged in to post a comment.

Not a member yet? Register now.
ADD TO PLAYLIST
REMOVE FROM PLAYLIST

Rate this

Click on a star to rate it.

Average rating / 5. Vote count:

No votes so far. Be the first to rate it.

TAGS
  • TAVR (TAVI)
  • Valve Disease

Related Content

Image 364
Video

ASAIO 2026 | Perioperative Catheter Ablation and LVAD Patients With Ventricular Arrhythmias

Dr. Crabtree OBAS Interview Standalone Thumbnail_3_2
Video

Oral Board AI Simulator: An Interview With Traves Crabtree

By: Traves Crabtree

The Beat Ep 9.24 Thumbnail_EPISODE
Podcast

The Beat With Joel Dunning Ep. 175: Oral Board AI Simulator

By: Joel DunningGold ContributorSilver Commentor

Image 363
Video

ASAIO 2026 | Stepdown Unit Management of Hemodynamically Stable Patients on Impella 5.5

ctsnet-jans-image
JANS Article

Mid-Term Outcomes After Bilateral Versus Single Internal Mammary Artery Grafting in MIDCAB

By: Shrikar Modukuri

ctsnet-jans-image
JANS Article

Comparison of RA and Saphenous Vein as the Third Conduit With BIMA in Coronary Bypass Surgery

By: Vincent SierGold Contributor

ctsnet-jans-image
JANS Article

Type A Aortic Dissection Causing Pulmonary Artery Intramural Hematoma and Compression

By: Shrikar Modukuri

TCRR Ep 11 Thumbnail_EPISODE
Podcast

The Cardiac Recovery Room: ECMO and ERAS—Awake, Extubate, Ambulate

By: Subhasis Chatterjee

Dr. Kempfert_ECS 2025 Thumbnail 900x506
Video

ECS Club | Endoscopic Team Training and Surgeon Mentorship

By: Joerg Kempfert

THT 09.15.2026 Webinar Thumbnail_16_9
Video

The TAVR Heart Team in 2026: Navigating the CMS Decision | A CTSNet Webinar

By: Tom C. NguyenSilver Contributor

233 S. Wacker Drive | Suite 4400
Chicago, Illinois 60606, USA

Linkedin X-twitter Facebook-f Youtube
  • Join CTSNet
  • Donate
  • Submit Content
  • Volunteer
  • Join CTSNet
  • Donate
  • Submit Content
  • Volunteer
  • Featured Partners
  • Careers
  • Press
  • Advertise on CTSNet
  • Featured Partners
  • Careers
  • Press
  • Advertise on CTSNet
  • CTSNet Policies
  • Privacy Policy
  • Disclaimer
  • Contact CTSNet
  • CTSNet Policies
  • Privacy Policy
  • Disclaimer
  • Contact CTSNet

233 S. Wacker Drive | Suite 4400
Chicago, Illinois 60606, USA

Instagram Linkedin X-twitter Facebook-f Youtube
  • Join CTSNet
  • Donate
  • Submit Content
  • Volunteer
  • Join CTSNet
  • Donate
  • Submit Content
  • Volunteer
  • Featured Partners
  • Careers
  • Press
  • Advertise on CTSNet
  • Featured Partners
  • Careers
  • Press
  • Advertise on CTSNet
  • CTSNet Policies
  • Privacy Policy
  • Disclaimer
  • Contact CTSNet
  • CTSNet Policies
  • Privacy Policy
  • Disclaimer
  • Contact CTSNet

233 S. Wacker Drive | Suite 4400
Chicago, Illinois 60606, USA

Instagram Linkedin X-twitter Facebook-f Youtube
  • Join CTSNet
  • Donate
  • Submit Content
  • Volunteer
  • CTSNet Policies
  • Privacy Policy
  • Join CTSNet
  • Donate
  • Submit Content
  • Volunteer
  • CTSNet Policies
  • Privacy Policy
  • Featured Partners
  • Careers
  • Press
  • Advertise on CTSNet
  • Disclaimer
  • Contact CTSNet
  • Featured Partners
  • Careers
  • Press
  • Advertise on CTSNet
  • Disclaimer
  • Contact CTSNet
  • Join CTSNet
  • Donate
  • Submit Content
  • Volunteer
  • Join CTSNet
  • Donate
  • Submit Content
  • Volunteer
  • Featured Partners
  • Careers
  • Press
  • Advertise on CTSNet
  • Featured Partners
  • Careers
  • Press
  • Advertise on CTSNet
  • CTSNet Policies
  • Privacy Policy
  • Disclaimer
  • Contact CTSNet
  • CTSNet Policies
  • Privacy Policy
  • Disclaimer
  • Contact CTSNet
© 2026 CTSNet Inc. All right reserved.
Go to Top